Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear Cell Renal Cell Carcinoma (ccRCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07688187
What this trial is testing

Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
PeptiDream Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT05119335
What this trial is testing

NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
ccRCCClear Cell Renal Cell CarcinomaKidney Cancer+14 more
NiKang Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT01649180
What this trial is testing

NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
PrECOG, LLC. 3
Not applicableStudy completedNCT06778538
What this trial is testing

Evaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma Patients

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)
Shang Panfeng 40
Very early researchWithdrawnNCT06708936
What this trial is testing

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)
Kousai Bio Co., Ltd.
Not applicableLooking for participantsNCT06088134
What this trial is testing

Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Clear Cell Renal Cell CarcinomaPrognostic Cancer ModelRecurrent Renal Cell Cancer
Mingzhao Xiao 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT06480565
What this trial is testing

A Phase 1/2 Trial of ADI-270 in ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Adicet Therapeutics 60
Early research (Phase 1)Looking for participantsNCT04777994
What this trial is testing

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
Advanced Solid Tumor Cancer
Calico Life Sciences LLC 248
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Testing effectiveness (Phase 2)Ended earlyNCT03875313
What this trial is testing

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more
Calithera Biosciences, Inc 33
Large-scale testing (Phase 3)Active Not RecruitingNCT05899049
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 251
Testing effectiveness (Phase 2)Looking for participantsNCT07571551
What this trial is testing

Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Jinling Hospital, China 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT06964958
What this trial is testing

177LuPSMA in Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaAdvanced Clear Cell Renal Cell CarcinomaKidney Cancer
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07077083
What this trial is testing

CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)ccRCC
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT03334409
What this trial is testing

Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+2 more
Academic and Community Cancer Research United 5
Not applicableStudy completedNCT06791863
What this trial is testing

Visceral Fat Area as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Multicenter Study on Postoperative Survival

Who this might be right for
ccRCC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,030
Large-scale testing (Phase 3)Looking for participantsNCT07011719
What this trial is testing

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaAdvanced Clear Cell Renal Cell Carcinoma
Arcus Biosciences, Inc. 720
Early research (Phase 1)Looking for participantsNCT07195682
What this trial is testing

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 281
Testing effectiveness (Phase 2)UnknownNCT03592199
What this trial is testing

Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib

Who this might be right for
Clear Cell Renal Cell Carcinoma
Instituto do Cancer do Estado de São Paulo 7
Testing effectiveness (Phase 2)Looking for participantsNCT05287945
What this trial is testing

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Oncorena AB 75
Next Page